Anthony E Lang Selected Research

Parkinson Disease (Parkinson's Disease)

06/2008	Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.
12/2007	Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.
07/2007	GDNF in Parkinson's disease: the perils of post-hoc power.
06/2007	Antidepressants and psychosis in Parkinson disease: a case series.
05/2007	Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease.
11/2006	Criteria for deep-brain stimulation in Parkinson's disease: review and analysis.
06/2006	Deep brain stimulation for Parkinson's disease.
04/2006	Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
03/2006	Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease.
03/2006	GDNF in treatment of Parkinson's disease: response to editorial.
02/2006	Crossroads in GDNF therapy for Parkinson's disease.
08/2005	Psychiatric symptoms in patients with Parkinson disease presenting for deep brain stimulation surgery.
03/2005	Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release.
03/2005	Analysis of the glucocerebrosidase gene in Parkinson's disease.
10/2004	Reproducibility of dopamine transporter density measured with 123I-FPCIT SPECT in normal control and Parkinson's disease patients.
10/2004	Subthalamic nucleus deep brain stimulation for parkinson's disease after successful pallidotomy: clinical and electrophysiological observations.
09/2004	Homocysteine and levodopa: should Parkinson disease patients receive preventative therapy?
06/2004	Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease.
05/2004	Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough.
03/2004	Antidepressants in the treatment of psychosis with comorbid depression in Parkinson disease.
01/2004	Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.
12/2003	Deep brain stimulation for Parkinson's disease dissociates mood and motor circuits: a functional MRI case study.
11/2003	Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release.
09/2003	Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease.
07/2003	Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.
06/2002	Dependence of subthalamic nucleus oscillations on movement and dopamine in Parkinson's disease.
03/2002	Treatment of excessive daytime sleepiness in patients with Parkinson's disease with modafinil.
01/2002	Deep brain stimulation for Parkinson's disease: patient selection and evaluation.

Articles by Research Topic

Disease

28	Parkinson Disease (Parkinson's Disease) 06/2008 - 01/2002
4	Dyskinesias (Dyskinesia) 11/2006 - 08/2004
2	Dystonia (Limb Dystonia) 03/2008 - 10/2007
2	Parkinsonian Disorders (Parkinsonism) 06/2007 - 08/2002
2	Tremor (Tremors) 12/2003 - 02/2003
1	Myoclonus (Nocturnal Myoclonus) 03/2008
1	Multiple System Atrophy 11/2007
1	Movement Disorders (Movement Disorder) 09/2007
1	Tauopathies 03/2006
1	Huntington Disease (Huntington's Disease) 03/2005
1	Heart Diseases (Heart Disease) 06/2004
1	Dystonic Disorders (Writer's Cramp) 03/2004

Drug/Important Bio-Agent (IBA)

7	Levodopa (L Dopa)FDA LinkGeneric 12/2007 - 07/2003
5	Dopamine (Intropin)FDA LinkGeneric 03/2005 - 06/2002
4	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 07/2007 - 02/2006
3	ropinirole (Requip)FDA LinkGeneric 12/2007 - 07/2003
3	Dopamine Agonists (Dopamine Agonist)IBA 11/2007 - 01/2004
2	Antidepressive Agents (Antidepressants)IBA 06/2007 - 03/2004
1	Uric Acid (Urate)IBA 06/2008
1	Sarcoglycans (beta Sarcoglycan)IBA 03/2008
1	ManganeseIBA 06/2007
1	monomethylpropion (methcathinone)IBA 06/2007
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 10/2006
1	Proteins (Proteins, Gene)IBA 03/2006
1	Glucosylceramidase (Glucocerebrosidase)IBA 03/2005
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 10/2004
1	HomocysteineIBA 09/2004
1	Dihydroxyphenylalanine (Dopa)IBA 08/2002
1	modafinil (armodafinil)FDA Link 03/2002

Therapy/Procedure

12	Deep Brain Stimulation 10/2007 - 01/2002
2	Pallidotomy 10/2004 - 03/2004
1	Ligation 09/2007
1	Transcutaneous Electric Nerve Stimulation (TENS) 02/2003